Research Analysts’ Weekly Ratings Changes for Sangamo Therapeutics (SGMO)
A number of firms have modified their ratings and price targets on shares of Sangamo Therapeutics (NASDAQ: SGMO) recently: 12/16/2024 – Sangamo Therapeutics was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 12/13/2024 – Sangamo Therapeutics was upgraded by analysts at Truist Financial Co. from a “hold” rating to a […]
More Stories
Bayerische Motoren Werke Aktiengesellschaft (FRA:BMW3) Stock Price Down 3% – Here’s What Happened
Bayerische Motoren Werke Aktiengesellschaft (FRA:BMW3 – Get Free Report)’s share price dropped 3% during mid-day trading on Tuesday . The...
Arcontech Group (LON:ARC) Shares Down 0.4% – Here’s What Happened
Arcontech Group plc (LON:ARC – Get Free Report) shares dropped 0.4% on Tuesday . The company traded as low as...
Grammer (ETR:GMM) Trading Down 1% – Here’s What Happened
Shares of Grammer AG (ETR:GMM – Get Free Report) fell 1% during trading on Tuesday . The company traded as...
Slate Office REIT (TSE:SOT.UN) Trading 1.3% Higher – Should You Buy?
Slate Office REIT (TSE:SOT.UN – Get Free Report)’s share price shot up 1.3% on Tuesday . The company traded as...
FY2024 EPS Estimates for AnaptysBio Lifted by HC Wainwright
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Research analysts at HC Wainwright increased their FY2024 earnings estimates for shares of...
Short Interest in Corpay, Inc. (NYSE:CPAY) Grows By 6.0%
Corpay, Inc. (NYSE:CPAY – Get Free Report) was the target of a large growth in short interest in the month...